Filters
Category
  • 28th January 2021VH Bio Blog

    *Position now filled* Molecular Biology Technical Sales Specialist

    Overview of VH Bio Ltd VH Bio Limited is a leading supply and distribution company for the life sciences industry within the United Kingdom and the Republic of Ireland, serving and specialising [...]

  • 28th January 2021VH Bio Blog

    *Position now filled* Next-Generation Sequencing (NGS) Technical Sales Specialist

    Overview of VH Bio Ltd VH Bio Limited is a leading supply and distribution company for the life sciences industry within the United Kingdom and the Republic of Ireland, serving and specialising [...]

  • 20th August 2020SMN1/2 Analysis

    Watch: Rapid, Comprehensive, and Complete SMN1/2 Profiling with the AmplideX® SMA Plus Kit (CE-IVD)

    Asuragen recently showcased their latest product developments via a live corporate satellite and scientific poster presentation at the European Human Genetics Virtual Conference ESHG 2020.2, which ran from June 6-9. The videos [...]

  • 29th June 2020SMN1/2 Analysis

    Webinar – Broad SMN1 and SMN2 profiling with the AmplideX® PCR/CE SMN1/2 Plus Kit

    Looking Beyond Copy Number: Broad SMN1 and SMN2 profiling in under four hours with the AmplideX® PCR/CE SMN1/2 Plus Kit (RUO)  Spinal muscular atrophy (SMA) is a devastating neurodevelopmental illness caused by a loss of SMN1 copies with disease severity [...]

  • 16th June 2020BCR-ABL1 Monitoring

    Webinar – The QuantideX® qPCR BCR-ABL IS Kit: A BCR-ABL Monitoring System that Meets and Exceeds Clinical Expectations for Testing

    Clinical expectations for BCR-ABL monitoring have evolved over time both in response to more sensitive tests being developed and new treatments and management approaches emerging. Largely in response to these medical advances, many [...]

  • Getting to know VH Bio’s new HLA tech specialist, Nav
    10th June 2020BCR-ABL1 Monitoring

    How the QuantideX® qPCR BCR-ABL IS Kit Provides a Simple, Sensitive, and Scalable BCR-ABL Monitoring Solution for a Laboratory

    To mark the launch of the ground-breaking Quantidex® QPCR BCR-ABL IS Kit, manufacturer Asuragen held a series of three webinars. We covered the first two webinars here and here, so head there [...]

  • 1st May 2020NGS, AllType

    AllType™ FASTplex™ – Combining Multiplex PCR with Workflow Simplicity

    Whilst most molecular HLA typing methodologies remain relatively static, next-generation sequencing (NGS) has tended to evolve quickly as product manufacturers respond to user suggestions, reagent development and changes in sequencing technology.  One [...]

  • 14th April 2020BCR-ABL1 Monitoring

    Analytical Validation of a BCR-ABL1 Monitoring System that Surpasses Current Testing Requirements

    To mark the launch of the ground-breaking Quantidex® QPCR BCR-ABL IS Kit, manufacturer Asuragen held a series of three webinars. We covered the first webinar here, so check that out first if [...]

  • 8th April 2020COVID-19, SARS-CoV-2

    Viral Molecular Transport Medium for Safer, Faster, No Cold Chain Shipping and Testing During COVID-19

    Quality molecular testing for the 2019 SARS-CoV-2 novel coronavirus requires optimised components at every stage of the testing process, beginning at sample collection. VH Bio is now able to offer a state-of-the-art [...]

  • 23rd March 2020COVID-19, SARS-CoV-2

    VH Bio offers Asuragen Armored RNA Quant® SARS-CoV-2 Control assays in UK

    VH Bio is supporting the fight against the Coronavirus pandemic with the addition of a new Asuragen-developed Armored RNA Quant® SARS-CoV-2 Control to its range, for use in developing assays in response [...]

  • 14th February 2020BCR-ABL1 Monitoring

    The Evolution of CML Patient Care and the Promise of Treatment-Free Remission – Webinar

    To mark the launch of the Quantidex® QPCR BCR-ABL IS Kit, manufacturer Asuragen held a series of three webinars that examine the evolving clinical landscape around CML, as well as the history [...]

  • 6th February 2020BCR-ABL1 Monitoring

    Best-in-class solution for assessment of major and minor BCR-ABL fusion transcripts

    The success and effectiveness of Tyrosine Kinase Inhibitors (TKIs) for treatment of Chronic Myeloid Leukaemia (CML) has altered clinical expectations as patients live longer, healthier lives. This success has, in itself, created [...]